Clinical Trial Update: Exparel vs Exparel Plus ACB in TKAs [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Exparel with Exparel plus adductor canal block in total knee arthroplasty for knee osteoarthritis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: The Hawkins Foundation | Conditions: Knee Osteoarthritis | Phase 4 | Status: WITHDRAWN